HighTower Advisors’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
BCC
HCL
MFP
SCM
QF
HighTower Advisors's ATEX Position: Q4 2021 in Review
HighTower Advisors sold out of Anterix (ATEX) in Q4 2021, closing a stake of 3,400 shares — an estimated $206K sold.
HighTower Advisors first reported a position in ATEX in Q3 2015 and held it in 4 quarters. The position peaked at $701K in Q1 2016. 108 funds tracked by Wall St. Rank hold ATEX as of Q4 2021.
- HighTower Advisors reported no remaining Anterix position as of Q4 2021 after selling out during the quarter.
- HighTower Advisors sold 3,400 Anterix shares in Q4 2021, an estimated $206K.
- HighTower Advisors first reported a position in Anterix in Q3 2015 and held it in 4 quarters.
- HighTower Advisors's Anterix position peaked at $701K in Q1 2016.
- 108 funds tracked by Wall St. Rank held Anterix as of Q4 2021.
Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.